Berkshire Hathaway Teva Pharma Industries Ltd ADR transactions over time
TEVA-OLD
Teva Pharma Industries Ltd ADR historical holders
total: 10
Transactions details
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 1
- Held since:
- 2017 Q4
- Held for:
- 16 quarters
- Latest activity:
- 2021 Q4
Warren Buffett has been an institutional investor in Teva Pharma Industries Ltd ADR (TEVA-OLD) since 2017 Q4. According to 2026 Q2 report, Warren Buffett doesn't hold any shares. The fund/company first acquired TEVA-OLD in 2017 Q4, initially purchasing about 18.88M shares. Since the initial investment, Berkshire Hathaway has made 4 more transactions in this position.
When did Warren Buffett exit their TEVA-OLD position?
Warren Buffett no longer holds Teva Pharma Industries Ltd ADR (TEVA-OLD). They sold off their entire position in 2021 Q4, closing out an investment that began in 2017 Q4.
When did Warren Buffett first invest in TEVA-OLD?
Warren Buffett first invested in Teva Pharma Industries Ltd ADR (TEVA-OLD) in 2017 Q4 at the reported quarter-end price of $18.95 per share, acquiring 18,875,721 shares in their initial purchase.
What is Warren Buffett's average cost basis for TEVA-OLD?
Based on historical transaction data, Warren Buffett's estimated cost basis for Teva Pharma Industries Ltd ADR (TEVA-OLD) is approximately $18.36 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $18.36
- Weighted AVG sell price:
- $9.73
TEVA-OLD transactions history by Berkshire Hathaway
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$9.74
|
|
-100% (-42,789,295)
|
-0.14%
|
|
2020 Q1
|
0.22%
|
$8.98
|
-1.06% (-460,000)
|
|||
|
2018 Q2
|
0.54%
|
$24.32
|
+6.68% (+2,709,585)
|
|||
|
2018 Q1
|
0.37%
|
$17.09
|
+114.77% (+21,663,989)
|
|||
|
2017 Q4
|
0.19%
|
$18.95
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.